About us

Our mission: to improve the lives of patients suffering from neurological diseases or injury to the central nervous system. We develop novel drug treatments and diagnostic approaches to reduce symptoms, disability and pain by targeting neuro-toxins which increase inflammation and damage nerve cells.

Neuro Vigor’s intellectual property is enabling development of more accurate diagnostics for the root causes of CNS disability and pain. Neuro Vigor Rx therapies are then precisely targeted to mitigate and potentially eliminate neuro-toxins associated with tissue inflammation and damaged nerve cells which result from these diseases. There are acute unmet needs for effective therapies with reduced side effects to address disorders such as multiple sclerosis, Parkinson’s disease, and neuropathic pain which are Neuro Vigor’s pipeline development priorities.

Neuro Vigor was founded in 2013 to monetize 15 years of path-breaking research of its co-founder, Dr. Riyi Shi, an internationally recognized Neurosciences MD and researcher who discovered the links between a specific neuro-toxin, Acrolein, and multiple neurological conditions. In animal studies, he also identified specific drugs which reduce Acrolein levels resulting in improvement in CNS symptoms. Neuro Vigor has protocols in place for advanced pre-clinical work designed to prepare the company for an FDA pre-IDE meeting focused on its first Acrolein Scavenger Rx product for multiple sclerosis.

In summary, Neuro Vigor’s focus and priority is an FDA cleared drug and companion diagnostic for MS. This product will favorably impact the remit & relapse cycles associated with MS and delay disease progression.

Management team

Dr. Riyi Shi

Founder

View full description

      David Giddings

      Founder

      view full description

        Mark Van Fleet

        Founder

        view full description

          Advisory Board

          Bernard Munos

          Strategic Advisor

              Dr. David Mattson

              Scientific advisor

              View full description

                Dr. Geanie Umberger

                Scientific advisor

                view full description

                  Partners

                  Ping Poulsen

                  Regulatory Advisor

                  view full description